Tom Price Considering Ending Birth Control Mandate
As Republicans move to repeal and replace the Affordable Care Act (ACA), HHS Secretary Tom Price, MD, may be eyeing the ACA’s birth control mandate, reported The Hill. As a congressman, Price opposed the mandate, which requires insurance companies cover free contraception. Reversing the mandate could be as easy as HHS excluding birth control from the list of women’s preventive health services that must be provided with no cost sharing.
Harvard Pilgrim Signs 2 New Pay-for-Performance Contracts
In Massachusetts, Harvard Pilgrim Health Care has signed 2 value-based contracts to pay for expensive drugs. Boston Globe reported that the deals are for Enbrel, a rheumatoid arthritis drug that costs about $45,000 a year, and Forteo, an osteoporosis drug that costs about $29,000 a year. The Enbrel contract is for 2 years and includes 6 criteria, while the Forteo contract allows Harvard Pilgrim to pay less for the drug over time if patients take it for 2 years.
Texas Cannot Cut Medicaid Funding to Planned Parenthood
Texas has become the latest state where an attempt to cut Medicaid funding to Planned Parenthood has been blocked. According to The New York Times, a federal judge temporarily blocked the state’s efforts because of a lack of evidence that Planned Parenthood providers violated medical or ethical standards. The state’s attorney general said Texas will appeal the injunction.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More